Join us for an evening of Healthcare Tech innovation with Hartwig Medical Foundation and GCUG
Calling all software developers and tech enthusiasts 🚀
Hartwig Medical Foundation partners with Google Cloud User Group (GCUG) to bring you an exclusive event showcasing the cutting-edge technology behind our clinical impact in cancer research and diagnostics.
🔍 What to Expect:
At Hartwig, our mission revolves around making a significant difference in the treatment of cancer in the Netherlands. While many are familiar with our clinical achievements, it’s time to pull back the curtain on the technical setup that powers our work. Our open-source software is a cornerstone of our success, and we’re thrilled to share it with the tech community.
📅 Event Details:
🗓️ Date: 11th July
📍 Location: Hartwig Medical Foundation Office, Science Park 404, Amsterdam
🍽️ Agenda:
- 17:30 Doors open
- 18:00 Dinner and Drinks: Network with fellow tech enthusiasts over delicious food and beverages.
- 18:15 Welcome and Tech Talk by Korneel: Dive into ACTIN, our innovative system for end-to-end automated treatment decision support for patients with metastatic cancer.
- 19:00 Short break
- 19:15 Tech Talks by Matthijs and Mathijs: Explore how we manage and store massive amounts of genomics data.
- 20:00 Tech Quiz: Wrap up the evening with a fun tech quiz!
- 20:15 Drinks & sync
This is a great opportunity to learn about the intersection of healthcare and technology, network with like-minded professionals, and gain insights into the groundbreaking work happening at Hartwig.
👉 RSVP here and secure your spot for an inspiring evening💡
You read an article in the category Working in the cloud. You may also be interested in Education, Hartwig Medical Database, Hartwig Medical Foundation, IT, Personalized treatment All newsAlso read
Hartwig visit to Jackson Laboratory in Farmington, CT
For interpretation of molecular results, Hartwig relies on the CKB resource that has been developed by The Jackson Laboratory, and …
In search of the optimal treatment strategy for glioblastoma
Patients with recurrent glioblastoma have an unfavorable outlook and few treatment options. The recently launched GLOW study should change this …
Complete DNA analysis for young adults with cancer
KWF finances the expansion of the infrastructure for cancer research in young adults with almost 4.5 million euros. These are …
Cancer is caused by DNA mutations. There are an increasing number of drugs available that act on specific errors in the DNA of an individual patient’s tumor. A drug that doesn’t fit, like a key in a lock, will not work, while the risk of side effects remains.